These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 25987296

  • 1. Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.
    Kawalec P, Holko P, Stawowczyk E, Borowiec Ł, Filipiak KJ.
    Kardiol Pol; 2015; 73(9):768-80. PubMed ID: 25987296
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective.
    Levy P, Lemański T, Crossan C, Lefebvre A, Brière JB, Degli Esposti L, Khan ZM.
    Expert Rev Pharmacoecon Outcomes Res; 2024 Oct; 24(8):967-975. PubMed ID: 38848115
    [Abstract] [Full Text] [Related]

  • 3. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Oct; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension.
    Tsioufis K, Douma S, Kallistratos MS, Manolis AJ.
    Clin Drug Investig; 2019 Apr; 39(4):385-393. PubMed ID: 30790132
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a new single-pill combination of a thiazide-like diuretic and a calcium channel blocker (indapamide sustained release/amlodipine) in essential hypertension.
    Dominiczak AF, de Champvallins M, Brzozowska-Villatte R, Asmar R, study coordinators, investigators.
    J Hypertens; 2019 Nov; 37(11):2280-2289. PubMed ID: 31246894
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study.
    Morabito G, Gregorio C, Ieva F, Barbati G, Mancia G, Corrao G, Rea F.
    BMC Public Health; 2024 Jul 06; 24(1):1808. PubMed ID: 38971775
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.
    Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, Grobbee DE, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Oparil S, Spiering W, Williams B, Wright JT, Lakshman P, Uluwattage W, Hay P, Pereira T, Amarasena N, Ranasinghe G, Gianacas C, Shanthakumar M, Liu X, Wang N, Gnanenthiran SR, Whelton PK, GMRx2 Investigators.
    Lancet; 2024 Oct 19; 404(10462):1536-1546. PubMed ID: 39426836
    [Abstract] [Full Text] [Related]

  • 8. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 19; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 9. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
    Malesker MA, Hilleman DE.
    Manag Care; 2010 Jul 19; 19(7):36-42. PubMed ID: 20672530
    [Abstract] [Full Text] [Related]

  • 10. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
    Tykarski A, Widecka K, Narkiewicz K, Wożakowska-Kapłon B, Gaciong Z, Grajek S, Grodzicki T, Januszewicz A, Wolf J, Prejbisz A, Kostka-Jeziorny K, Filipiak KJ.
    Kardiol Pol; 2017 Jul 19; 75(12):1357-1367. PubMed ID: 29251761
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C, Sieder C, Meister F, Kaiser E.
    Curr Med Res Opin; 2012 Jan 19; 28(1):69-78. PubMed ID: 22117838
    [Abstract] [Full Text] [Related]

  • 12. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A, Galera Llorca J, Muñoz Ortí G, Navarro Artieda R.
    Med Clin (Barc); 2011 Feb 26; 136(5):183-91. PubMed ID: 21106209
    [Abstract] [Full Text] [Related]

  • 13. Blood-pressure Lowering Efficacy and Safety of Perindopril / Indapamide / Amlodipine Single-pill Combination in Hypertensive Patients: Phase III Trial in India.
    Thacker H, Konda Reddy KM, Murthy LS, Sawhney JP, Chaudhary G, Shah S, Joseph S, Rajarshi M, Nikam P.
    J Assoc Physicians India; 2020 Oct 26; 68(10):39-43. PubMed ID: 32978924
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure control with a single-pill combination of indapamide sustained-release and amlodipine in patients with hypertension: the EFFICIENT study.
    Jadhav U, Hiremath J, Namjoshi DJ, Gujral VK, Tripathi KK, Siraj M, Shamanna P, Safar M.
    PLoS One; 2014 Oct 26; 9(4):e92955. PubMed ID: 24714044
    [Abstract] [Full Text] [Related]

  • 15. Blood pressure control and acceptability of perindopril and its fixed dose combinations with amlodipine or indapamide, in younger patients with hypertension.
    Bansal S, Chauhan DK, Ramesh D, Barmare S, Chakraborty S.
    Indian Heart J; 2014 Oct 26; 66(6):635-9. PubMed ID: 25634398
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
    Tóth K, PIANIST Investigators.
    Am J Cardiovasc Drugs; 2014 Apr 26; 14(2):137-45. PubMed ID: 24590580
    [Abstract] [Full Text] [Related]

  • 17. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K.
    J Cardiovasc Pharmacol; 2008 Jun 26; 51(6):590-5. PubMed ID: 18520951
    [Abstract] [Full Text] [Related]

  • 18. Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
    Okamura K, Shirai K, Totake N, Okuda T, Urata H.
    Clin Exp Hypertens; 2018 Jun 26; 40(2):99-106. PubMed ID: 28692311
    [Abstract] [Full Text] [Related]

  • 19. A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    Snyman JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, Konradi AO, Perrone V, Borghi C.
    J Hypertens; 2024 Jan 01; 42(1):136-142. PubMed ID: 37728093
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.
    Hanon O, Boully C, Caillard L, Labourée F, Cochiello S, Chaussade E.
    Am J Hypertens; 2015 Aug 01; 28(8):1064-71. PubMed ID: 25628416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.